JOIN US

for the 4th International BRCA Forum 21 AUGUST 2020 which will be one of the foremost International Scientific Virtual Forum on Hereditary Cancer

iBRCAf Forum- 21 August 2020 | APGCS - 22 -23 August 2020

CME applied with European Accreditation
Council for Continuing Medical Education

CME applied with Singapore Medical Council

  • Detailed interactive event agenda
  • Personal custom agenda for specific attendees
  • Attendees can save specific sessions to their personal agenda
  • Live stream conference sessions, networking and interaction
  • Questions can be asked live from anywhere
  • Easily cycle between sessions, video, comments and Q&A
  • Includes a filterable, tiered directory of sponsors/exhibitors
  • Dedicated profile for each company including information, downloads, products and video
  • Interact with assigned representatives immediately
  • Virtual industry sponsored satellite symposia
  • Allow onsite and offsite participants to ask questions live
  • All participants can ask and view questions anywhere in the world
  • Questions are shown beneath your live streaming sessions
  • Send live polls to onsite and offsite participants instantly
  • All participants can respond to polls anywhere in the world
  • Instant Messaging available between onsite and offsite participants
  • Ability to filter between onsite and offsite participants
  • Network and set up virtual face to face meetings with other users
  • Participants can connect via video call to the members of your team
  • Connect with onsite and offsite participants
  • Offsite participants provided with a virtual meeting automatically
  • In-App live video calling
  • Auto notification when the virtual meeting begins
  • Make notes and download post meeting

WELCOME MESSAGE

Dear Colleagues and Partners,

We are delighted to welcome you to a virtual venture to the 4th International BRCA Forum(iBRCAf) 2020! As there is a constant need to keep our healthcare experts updated with latest breakthroughs in Medical Education, IBRCAF is officially going virtual to deliver insightful and interactive learning right at the safety of your homes.

As we progress with the infinite possibilities of genetic oncology, BRCA gene mutation is rapidly emerging to become an important agnostic marker for therapy with PARPi with applications in the realm of breast, ovarian and pancreatic cancers. The scientific committee and faculty of iBRCAf for the past three years has been working very hard to bring healthcare professionals under one roof to discuss new research and best practices. Acknowledging that molecular profiling of tumors is rapidly becoming an integral part of management the scientific committee is looking forward to put together a program that will cover a broad-spectrum topic looking at therapeutic targets including BRCA and beyond. How do we test for these targets? Is comprehensive profiling important in every practice? How do we best incorporate them into management strategies? These are a few of the questions we will be asking this year.

This 4th edition of iBRCAf is focused to highlight regional viewpoints into BRCA related malignancies, going beyond BRCA to determine emerging important targets, and to share experiences so we can learn from each other. The two-day program will certainly have something to wet the appetites of everyone and our tumor boards will provide a platform for sharing of practical cases. Our local, regional and international faculty will ensure a highly interactive and fruitful conference.

iBRCAf  COMMITTEE

Shaheenah Dawood
UAE

Shona Nag
India

Forum Objective

  • Pathogenesis of BRCA pathway
  • Clinical applications of PARP inhibitors across solid tumor types
  • Molecular tumor boards using molecular profiling of solid tumors
  • Defining importance of profiling tumors for personalized approaches to therapeutic management
  • Handling toxicities of targeted therapy including PARPi and beyond
  • Genetic counseling of patients with germline mutations
  • Deep dive into interpreting molecular profiling reports
  • A global look at BRCA mutations

Who Should Attend

  • Oncologist
  • Physician
  • Nurse
  • General Practitioner
  • Resident
  • Consultant
  • Obs-Gyne
  • Pharmacist

Support Sponsor

Networking Sponsors

AstraZeneca

IPS Genomix

Caris

iBRCAf 2020 Supported by